Work

NSCLC, early stage Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw435.38

Institutions: Johns Hopkins University, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Bristol-Myers Squibb

OpenAlex ID: W2558656135

FWCI: 2.48

Cites:

Cited by: 18

Related to: 10